title: Relationship of body-weight gain to longevity and to risk of development of nephropathy and neoplasia in Sprague-Dawley rats.
abstract: The relationship of weight gain to survival, risk of development of chronic progressive nephropathy and risk of development of various neoplasms has been studied in the control groups from two routine chronic toxicity studies in Sprague-Dawley rats. The groups comprised 100 CFY strain rats of each sex observed up to the age of 109 wk and 120 CD strain rats of each sex observed up to 111 wk of age (females) or 121 wk (males). The eventual incidence of tumours was found to be related to body weight at several ages. There was also a statistically significant association between high body weight at various ages and increased mortality, particularly in the CD strain and particularly in females. The 'heavy' rats proved to have an increased risk of developing both progressive nephropathy and certain tumours. This relationship was particularly marked for pituitary tumours in both sexes and for benign and malignant mammary tumours in females, and was significant irrespective of whether tumours coexisting with marked or severe progressive nephropathy were classified as fatal or incidental. There was also some evidence that increased body weight was positively associated with risk of islet-cell tumours and lipomatous tumours in males and fibromatous tumours in females. The observations illustrate how non-specific factors, such as those that affect body weight, may profoundly influence mortality and tumour incidence in chronic toxicity studies. The findings also highlight the difficulty of classifying particular neoplasms as incidental or fatal where other potentially life-threatening pathology (e.g. progressive nephropathy) is present.
authors.forename: G J
authors.initials: GJ
authors.lastname: Turnbull
authors.forename: P N
authors.initials: PN
authors.lastname: Lee
authors.forename: F J
authors.initials: FJ
authors.lastname: Roe
mesh_terms: D000230:Adenocarcinoma / Q000662:veterinary; D000232:Adenofibroma / Q000662:veterinary; D000236:Adenoma / Q000662:veterinary; D007516:Adenoma, Islet Cell / Q000662:veterinary; D000818:Animals; D001835:Body Weight; D005260:Female; D005350:Fibroma / Q000662:veterinary; D007674:Kidney Diseases / Q000453:epidemiology / Q000662:veterinary*; D008136:Longevity; D008297:Male; D008321:Mammary Glands, Animal; D009369:Neoplasms / Q000453:epidemiology / Q000662:veterinary*; D010190:Pancreatic Neoplasms / Q000662:veterinary; D010911:Pituitary Neoplasms / Q000662:veterinary; D051381:Rats; D011919:Rats, Inbred Strains / Q000033:anatomy & histology / Q000502:physiology*; D012189:Retrospective Studies; D012306:Risk; D012376:Rodent Diseases / Q000453:epidemiology